Combination therapy in rheumatoid arthritis
66 results
1 - 66
Combination therapy in rheumatoid arthritis - Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review- Delay to institution of therapy and induction of remission using single-drug or combination antirheumatic drug therapy in early rheumatoid arthritis
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis New
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review
- Rheumatoid arthritis
- Adalimumab for treating rheumatoid arthritis Edited (no change to conclusions)
- Effect of combination drug therapy on rheumatoid atlantoxial subluxations
- Antimalarials for treating rheumatoid arthritis Edited (no change to conclusions)
- Short‐term induction glucocorticoids and disease‐modifying anti‐rheumatic drugs (DMARD) therapy for rheumatoid arthritis New
- Thermotherapy for treating rheumatoid arthritis Edited (no change to conclusions)
- Balance training (proprioceptive training) for patients with rheumatoid arthritis: Cochrane systematic review
- Therapeutic ultrasound for the treatment of rheumatoid arthritis Edited (no change to conclusions)
- Infliximab for the treatment of rheumatoid arthritis Edited (no change to conclusions)
- Juvenile idiopathic arthritis (juvenile rheumatoid arthritis)
- Anakinra for rheumatoid arthritis: Cochrane systematic review
- Adalimumab for treating rheumatoid arthritis
No increased risk of cancer with biologic therapy for rheumatoid arthritis- Anakinra for rheumatoid arthritis
- Tocilizumab for rheumatoid arthritis: Cochrane systematic review
- Opioid therapy for treating rheumatoid arthritis pain
- Adding MTX to sulfasalazine better for RA (MASCOT)
- Herbal therapy for rheumatoid arthritis
- Auranofin versus placebo in rheumatoid arthritis Edited (no change to conclusions)
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Tocilizumab for rheumatoid arthritis
- RA options: MTX still first-line
- Gryphotic nails with fungal infection caused by T. rubrum - Image
- Opioid therapy for treating rheumatoid arthritis pain: Cochrane systematic review
- Leflunomide for the treatment of rheumatoid arthritis Edited (no change to conclusions)
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Updated ACR guideline on managing patients with rheumatoid arthritis
- Injectable gold for rheumatoid arthritis Edited (no change to conclusions)
- Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis New
- Leflunomide for rheumatoid arthritis
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis New
- Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
- Methotrexate for treating juvenile idiopathic arthritis Edited (no change to conclusions)
- Combined chiropractic interventions for low‐back pain Edited (no change to conclusions)
- Muscle relaxants for pain management in rheumatoid arthritis: Cochrane systematic review
- Rituximab for rheumatoid arthritis: Cochrane systematic review
- Bronchiectasis
- Physiotherapy interventions for shoulder pain Edited (no change to conclusions)
- Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview Edited (no change to conclusions)